4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-048028
Options or other derivatives
- Chief Medical Officer acquired 11,286 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2018-08-20 | Grant or award · Restricted Stock Units | +11,286 | 11,286 | D | ||
Loading xslF345X03/doc4.xml…